Liquidia LQDA
NASDAQ LQDA
$68.73 +1.05 (+1.55%)
As of: Sep 9, 2026 · 3:10 PM EDT

Liquidia (LQDA) Depreciation & Amortization (CF) (2020 - 2026)

Liquidia (LQDA) posted Depreciation & Amortization (CF) of $400000.0 for Q2 2026, down 19.52% on a QoQ basis from $497000.0 in Q1 2026, and up 42.35% year-over-year from $281000.0 in Q2 2025.

Analysis

Liquidia (LQDA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Liquidia has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $400000.0 in Q2 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 42.35% year-over-year to $400000.0 in Q2 2026; TTM through Jun 2026 was $1.7 million, a 8.98% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 30.45% from the prior year.
  • Depreciation & Amortization (CF) was $400000.0 for Q2 2026 at Liquidia, down from $497000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $1.1 million in Q3 2022, with the low at $281000.0 in Q2 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $580388.9, with a median of $516000.0 recorded in 2023.
  • The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) slumped 54.43% in 2023, then soared 42.35% in 2026.
  • Over 5 years, Depreciation & Amortization (CF) stood at $566000.0 in 2022, then retreated by 10.6% to $506000.0 in 2023, then increased by 2.37% to $518000.0 in 2024, then slumped by 38.22% to $320000.0 in 2025, then increased by 25.0% to $400000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $400000.0 (Q2 2026), $497000.0 (Q1 2026), and $320000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Johnson & Johnson 646.43 Bn 625.67 Bn 17.26 Bn 1.96 Bn
2 AbbVie 442.46 Bn 435.89 Bn 12.70 Bn -
3 Merck 366.77 Bn 359.63 Bn 12.21 Bn -
4 Novartis Ag 266.59 Bn 258.90 Bn 11.24 Bn -
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 1.62 Bn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn 3.97 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn - -
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 26.48 Mn
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn 24.20 Mn
10 Liquidia 6.11 Bn 5.82 Bn 160.92 Mn 400,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 400,000.00
Mar 31, 2026 497,000.00
Dec 31, 2025 320,000.00
Sep 30, 2025 476,000.00
Jun 30, 2025 281,000.00
Mar 31, 2025 451,000.00
Dec 31, 2024 518,000.00
Sep 30, 2024 610,000.00
Jun 30, 2024 580,000.00
Mar 31, 2024 489,000.00
Dec 31, 2023 506,000.00
Sep 30, 2023 514,000.00
Jun 30, 2023 589,000.00
Mar 31, 2023 569,000.00
Dec 31, 2022 566,000.00
Sep 30, 2022 1.13 Mn
Jun 30, 2022 1.01 Mn
Mar 31, 2022 947,000.00
Dec 31, 2021 872,000.00
Sep 30, 2021 1.55 Mn